Fort Lauderdale, Fla. • (954) 677-9201 • www.homediagnosticsinc.com
Exchange and Ticker: Nasdaq: HDIX
Filing Range: 3.3M shares @ $14 to $16
Offering Price: $12
Close on First Day: $12.60
Offering Size: $79.2M
Shares Outstanding: 17.58M
Underwriter: JP Morgan
Co-managers: Deutsche Bank Securities Corp./ William Blair & Co.
Company Counsel: Satterlee, Stephens, Burke & Burke
Manager Counsel: Cahill Gordon & Reindel
Auditor: Pricewaterhouse Coopers LLP
Market Capitalization on 9/30/06: $230.1M
Close price at current month end: $13.10
Home Diagnostics manufactures medical diagnostic products. It provides diabetes products to retail pharmacy, mail service home medical and the medical marketplace. It also provides blood glucose monitoring systems to monitor and manage patients with diabetes. The Company markets products through these distribution. Competitors include Bayer, Becton Dickinson, LifeScan (a division of Johnson & Johnson), the MediSense and TheraSense divisions of Abbott Laboratories, and Roche.
Albion Alliance, CIVC Partners, Gateway Associates, Medical Innovation Partners, Norwest Venture Partners, Parsnip River Co., Sears Investment Management Co., TA Associates, TVM Capital.
Source: Thomson Financial